ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Sarcosine → HCID 178444710、化合物

HRID 730499
印刷

反応式

HRID 730499 の反応式
[CH3:1][C:2]([CH3:30])([CH3:29])[CH2:3][CH2:4][N:5]1[C:10](=[O:11])[C:9]([C:12]2[NH:17][C:16]3[CH:18]=[CH:19][C:20](I)=[CH:21][C:15]=3[S:14](=[O:24])(=[O:23])[N:13]=2)=[C:8]([OH:25])[C:7]2=[CH:26][CH:27]=[CH:28][N:6]12.[O-]P(OP(OP([O-])([O-])=O)([O-])=O)(=O)[O-].[K+].[K+].[K+].[K+].[K+].N(CC(O)=O)C.[CH3:55][S:56]([NH2:59])(=[O:58])=[O:57]>[Cu]I.CN(C)C=O>[CH3:1][C:2]([CH3:30])([CH3:29])[CH2:3][CH2:4][N:5]1[C:10](=[O:11])[C:9]([C:12]2[NH:17][C:16]3[CH:18]=[CH:19][C:20]([NH:59][S:56]([CH3:55])(=[O:58])=[O:57])=[CH:21][C:15]=3[S:14](=[O:24])(=[O:23])[N:13]=2)=[C:8]([OH:25])[C:7]2=[CH:26][CH:27]=[CH:28][N:6]12
参加物実験手順後処理出典と根拠反応ノート

参加物

7

反応物 4

HCID 1088SarcosineHCID 61695Pentapotassium TriphosphateHCID 72879MethanesulfonamideHCID 178444709HCID 178444709、化合物

生成物 1

HCID 178444710HCID 178444710、化合物収率 51%

試薬・触媒・溶媒 2

HCID 24350
Copper(1+) iodide; Copper(I) iodide; Cuprous iodide; Cuprous iodide (CuI)
触媒
HCID 6228Dimethylformamide溶媒

実験手順

1-(3,3-Dimethyl-butyl)-4-hydroxy-3-(7-iodo-1,1-dioxo-1,4-dihydro-1λ6-benzo[1,2,4]thiadiazin-3-yl)-pyrrolo[1,2-b]pyridazin-2-one (Example 4d, 0.065 g, 0.120 mmol), potassium triphosphate (0.128 g, 0.60 mmol), sarcosine (0.006 g, 0.072 mmol), and copper (I) iodide (0.006 g, 0.03 mmol) were combined. Anhydrous N,N-dimethylformamide (2 mL) was added followed by methanesulfonamide (0.114 g, 1.2 mmol). The solution was degassed while stirring under vacuum and the flask was purged with nitrogen. The mixture was stirred at 100° C. for 2 h. Upon cooling, the mixture was diluted with ethyl acetate (100 mL), washed with 1.0 M aqueous hydrochloric acid solution (3×50 mL) and dried over magnesium sulfate. The entire organic layer was passed through a plug of silica gel. The filtrate was concentrated in vacuo to afford a solid. The solid was triturated with a 1:1 mixture of ethyl acetate and hexanes, collected by vacuum filtration, triturated with methanol and collected by vacuum filtration. The solid was dried in vacuo for 16 h to afford the desired product, N-{3-[1-(3,3-dimethyl-butyl)-4-hydroxy-2-oxo-1,2-dihydro-pyrrolo[1,2-b]pyridazin-3-yl]-1,1-dioxo-1,4-dihydro-1λ6-benzo[1,2,4]thiadiazin-7-yl}-methanesulfonamide (0.031 g, 0.061 mmol, 51% yield) as a pale yellow powder. 1H NMR (400 MHz, DMSO-d6) δ: 1.01 (9H, s), 1.57-1.62 (2H, m), 3.07 (3H, s), 4.39-4.43 (2H, m), 6.70-6.72 (1H, m), 7.03 (1H, d, J=3.8 Hz), 7.53 (1H, dd, J1=8.7 Hz, J2=2.8 Hz), 7.60 (1H, d, J=2.3 Hz), 7.67 (1H, d, J=8.4 Hz), 7.75 (1H, s), 10.20 (1H, s), 13.72 (1H, bs). LC-MS (ESI) calcd for C21H25N5O6S2, found 507.12, found 508.36 [M+H+].

後処理

  1. customThe solution was degassed
  2. customthe flask was purged with nitrogen
  3. stirringThe mixture was stirred at 100° C. for 2 h
  4. temperatureUpon cooling
  5. additionthe mixture was diluted with ethyl acetate (100 mL)
  6. washwashed with 1.0 M aqueous hydrochloric acid solution (3×50 mL)
  7. dry with materialdried over magnesium sulfate
  8. concentrationThe filtrate was concentrated in vacuo
  9. customto afford a solid
  10. customThe solid was triturated with a 1:1 mixture of ethyl acetate and hexanes
  11. filtrationcollected by vacuum filtration
  12. customtriturated with methanol
  13. filtrationcollected by vacuum filtration
  14. customThe solid was dried in vacuo for 16 h

出典と根拠

ORDレコード
ord-4406335146004e42bdf2cfabe61c5392
出典データセット
uspto-grants-2009_09
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US07582754B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート